Value-based Care in Type 2 Diabetes (Enhancing T2D Care)
NCT ID: NCT06774950
Last Updated: 2025-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
154 participants
INTERVENTIONAL
2025-03-01
2027-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This will be achieved through an intervention that includes a strategy for training primary care physicians and other healthcare professionals in patient therapeutic education (TPE), as well as group and/or individual TPE-related activities/tools made available to patients, funded and encouraged for individualized planning. Intervention follow-up will be carried out by means of quality-of-life questionnaires for patients who have undergone the new method, compared with patients who have received the usual care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IMPACT Intervention
NCT04616053
Impact of a Multidisciplinary Therapeutic Education Program Being Set up for Patients With Type 2 Diabetes Mellitus
NCT03192228
Social Support Intervention for Self-management of Type 2 Diabetes Mellitus
NCT04491253
The Effects of Self-management Education Based on Theory of Planned Behavior on Patients With Type 2 Diabetes
NCT02594748
T2D Pilot Study for Patients With Uncontrolled Type 2 Diabetes
NCT06988540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Usual care
No interventions assigned to this group
Intervention arm
Physician-patient quality circle
Intervention: (To be compared with standard care)
1. Interprofessionnal meeting per neighbourhood: (beforehand) Therapeutic patient education (TPE) training for healthcare professionals
2. Physician-patient quality circle t0 Group sessions (n= 3 to 6 patients) with doctor and therapeutic patient education specialist Clinical measurements - CM (incl. HbA1c, body composition, blood pressure). PROM evaluation questionnaires (EQ5D\&DIABQ)
3. Development of individualised T2D programme: with case manager
4. Quarterly follow-up: t3, t6, t9 months PROM follow-up (DIABQ\&PHQ9) +CM.
5. Evaluation of experience: t12 \& t18 months PREM\&PROM evaluation questionnaire +CM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physician-patient quality circle
Intervention: (To be compared with standard care)
1. Interprofessionnal meeting per neighbourhood: (beforehand) Therapeutic patient education (TPE) training for healthcare professionals
2. Physician-patient quality circle t0 Group sessions (n= 3 to 6 patients) with doctor and therapeutic patient education specialist Clinical measurements - CM (incl. HbA1c, body composition, blood pressure). PROM evaluation questionnaires (EQ5D\&DIABQ)
3. Development of individualised T2D programme: with case manager
4. Quarterly follow-up: t3, t6, t9 months PROM follow-up (DIABQ\&PHQ9) +CM.
5. Evaluation of experience: t12 \& t18 months PREM\&PROM evaluation questionnaire +CM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age (between 40 and 65)
Exclusion Criteria
* Pregnant or breast-feeding women
* Persons who are unable to give signed informed consent
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of St. Gallen - School of Medicine
UNKNOWN
Réseau de soins Delta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Minette-Joëlle Zeukeng
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Geissler, PhD
Role: STUDY_CHAIR
University of St. Gallen - School of Medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNCTP000006190
Identifier Type: OTHER
Identifier Source: secondary_id
2024-01350
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.